The decline of pharmaceutical psychiatry and the increasing role of psychological medicine.
The increasing influence of the pharmaceutical industry on psychiatric research and practice is leading to an intellectual and clinical crisis. A narrow concept of science attempts to apply oversimplified neurobiological models to the understanding and treatment of mental disorders, and relegates psychiatrists to a marginal role. This paper reviews some emerging trends of renewal that may be subsumed under the rubric of psychological medicine: use of a multidisciplinary approach, emphasis on psychotherapeutic strategies leading to self-management, reliance on repeated assessments, integration of different treatment modalities and independence from the pharmaceutical industry. The concept of psychological medicine, defined as the clinical application of the psychosomatic approach, may provide room for innovative paths in psychiatric research and treatment.
Fava
Giovanni A
GA
Affective Disorders Program, Department of Psychology, University of Bologna, Bologna, Italy. giovanniandrea.fava@unibo.it
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000639:trends; D003131:Combined Modality Therapy; D016265:Conflict of Interest; D003866:Depressive Disorder / Q000628:therapy; D030881:Disclosure; D004345:Drug Industry / Q000639:trends*; D004348:Drug Labeling; D005544:Forecasting; D006801:Humans; D001523:Mental Disorders / Q000628:therapy*; D010348:Patient Care Team / Q000639:trends; D011570:Psychiatry / Q000639:trends*; D011600:Psychopharmacology / Q000639:trends*; D011611:Psychosomatic Medicine / Q000639:trends*; D011613:Psychotherapy / Q000639:trends*; D017594:Publication Bias; D012648:Self Care / Q000639:trends
D000928:Antidepressive Agents